On June 18, 2024, France introduced the tariffs of €10-€15 for rapid diagnostic tests performed by pharmacists. This initiative enables pharmacists to swiftly diagnose and manage common conditions, such as Group A Streptococcal pharyngitis and urinary tract infections.

On June 18, 2024, the Swiss Federal Office of Public Health published the changes that will occur to the Services Ordinance (KLV/OPre), which determines coverage of medical services in Switzerland. The updates will enter into force on July 1, 2024, and they relate to the list of explicitly evaluated services (Annex 1 of KLV/OPre), outpatient-before-hospital services (Annex 1a), List of Tools and Equipment (Annex 2), and List of Analyses (Annex 3).

On June 7, 2024, the Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) informed that the federal government, states, and sickness funds have agreed on concrete actions to implement healthcare reform. The reform will focus on various aspects, such as establishment of special outpatient clinics, the expansion of primary care, and improvement of the situation of digital healthcare.

On June 10, 2024, the National Agency for Regional Health Services (AGENAS) announced an online public consultation on the draft of the “Guidelines on the Evolutionary Pathway of Medical Systems for Telemonitoring”.

In the first half of June 2024, the French National Authority for Health (HAS) published its positive opinions regarding the reimbursement of several services in France.

In May 2024, a new NICE-wide topic prioritization manual was published. The manual sets out the process for how new guidance topics and updates to existing NICE guidance are identified, prioritized, and routed at NICE, as well as the decision-making framework used by the newly established prioritization board.

In June 2024, the following ongoing mini-HTA assessments for cardiovascular, diagnostic imaging, e-health, endoscopy, gastrointestinal, in-vitro diagnostics, men’s health, neurology and neurosurgery, neuromodulation, peripheral vascular, pulmonary and airways, robotic surgery, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway.

In May 2024, the National Institute for Health and Care Research (NIHR) in England released one MedTech-related assessment in its Health Technology Assessment (HTA) Journal, which concerned Doppler ultrasound surveillance of a recently formed hemodialysis arteriovenous fistula. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

On May 27, 2024, the Danish Health Technology Council released two new publications: an evaluation of Optune® (Novocure) and a major analysis on the treatment of obstructive sleep apnea.

On May 27, 2024, the Innovation Committee at the Federal Joint Committee (G-BA) announced that ninety-one applications (project ideas) for innovation funding of the projects for new forms of care were received.

On May 23, 2024, the Norwegian Directorate of Health released an updated version of the Norwegian Laboratory Code (NLK) system and associated tariffs to be implemented no later than July 1, 2024. Twenty-two new codes were added, and 49 codes were changed.

In May 2024, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedures Guidance concerning selective internal radiation therapy for liver metastases, endoscopic duodenal mucosal resurfacing in type 2 diabetes, and image-guided percutaneous laser ablation for liver tumours, and one Diagnostics Guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer.